Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PubMed

The oversight of autonomous artificial intelligence: lessons from nurse practitioners as physician extenders.

PMID: 35968225 ·

W, a, l, k, e, r, , M, o, r, r, e, l, l, ;, , C, a, r, m, e, l, , S, h, a, c, h, a, r, ;, , A, n, t, h, o, n, y, , P, , W, e, i, s, s

RevistaJournal of law and the biosciences
Año
PMID35968225

Resumen

The development of autonomous artificial intelligence (A-AI) products in health care raises novel regulatory challenges, including how to ensure their safety and efficacy in real-world settings. Supplementing a device-centered regulatory scheme with a regulatory scheme that considers A-AI products as a 'physician extender' may improve the real-world monitoring of these technologies and produce other benefits, such as increased access to the services offered by these products. In this article, we

Fuente oficial

Ver en PubMed →

Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.

↑